No photo of Alexey Ryazanov

View Scopus Profile

Alexey Ryazanov

  • 4718 Citations
  • 36 h-Index
1984 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Alexey Ryazanov is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Use of EF2K inhibitors to inhibit tumor growth and sensitize cancer cells to existing chemotherapy treatment

Ryazanov, A.

National Institutes of Health

6/10/15 → 5/31/16

Project: Research project

    • Use of EF2K Inhibitors to Reduce Toxicity to Normal Tissues in Chemotherapy

    Ryazanov, A.

    National Institutes of Health

    8/1/14 → 7/1/15

    Project: Research project

    • Investigation of synergism between mTOR and eEF2 kinase pathways

    Ryazanov, A.

    National Institutes of Health

    9/30/12 → 8/31/14

    Project: Research project

    • Translational Control of Radiation-Induced Apoptosis

    Ryazanov, A.

    National Institutes of Health

    12/1/09 → 11/30/14

    Project: Research project

    • Development of New Drugs that Protect Gastrointestinal Tract from Radiation

    Ryazanov, A.

    National Institutes of Health

    9/1/07 → 2/28/11

    Project: Research project

    • Research Output

    Chanzyme TRPM7 protects against cardiovascular inflammation and fibrosis

    Rios, F. J., Zou, Z. G., Harvey, A. P., Harvey, K. Y., Nosalski, R., Anyfanti, P., Camargo, L. L., Lacchini, S., Ryazanov, A. G., Ryazanova, L., McGrath, S., Guzik, T. J., Goodyear, C. S., Montezano, A. C. & Touyz, R. M., Mar 1 2020, In : Cardiovascular research. 116, 3, p. 721-735 15 p.

    Research output: Contribution to journal › Article

    Open Access
    • 7 Scopus citations

    Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer’s disease model mice

    Beckelman, B. C., Yang, W., Kasica, N. P., Zimmermann, H. R., Zhou, X., Keene, C. D., Ryazanov, A. G. & Ma, T., Feb 1 2019, In : Journal of Clinical Investigation. 129, 2, p. 820-833 14 p.

    Research output: Contribution to journal › Article

    • 9 Scopus citations

    Glycine supplementation extends lifespan of male and female mice

    Miller, R. A., Harrison, D. E., Astle, C. M., Bogue, M. A., Brind, J., Fernandez, E., Flurkey, K., Javors, M., Ladiges, W., Leeuwenburgh, C., Macchiarini, F., Nelson, J., Ryazanov, A. G., Snyder, J., Stearns, T. M., Vaughan, D. E. & Strong, R., Jun 2019, In : Aging cell. 18, 3, e12953.

    Research output: Contribution to journal › Article

    Open Access
    • 5 Scopus citations

    Correction to: eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis (Oncogene, (2016), 35, 49, (6293-6308), 10.1038/onc.2016.166)

    Cheng, Y., Ren, X., Yuan, Y., Shan, Y., Li, L., Chen, X., Zhang, L., Takahashi, Y., Yang, J. W., Han, B., Liao, J., Li, Y., Harvey, H., Ryazanov, A., Robertson, G. P., Wan, G., Liu, D., Chen, A. F., Tao, Y. & Yang, J. M., Aug 16 2018, In : Oncogene. 37, 33, p. 4633-4634 2 p.

    Research output: Contribution to journal › Comment/debate

    • Genetic removal of eIF2α kinase PERK in mice enables hippocampal L-LTP independent of mTORC1 activity

    Zimmermann, H. R., Yang, W., Beckelman, B. C., Kasica, N. P., Zhou, X., Galli, L. D., Ryazanov, A. G. & Ma, T., Jul 2018, In : Journal of neurochemistry. 146, 2, p. 133-144 12 p.

    Research output: Contribution to journal › Article

    • 6 Scopus citations